The Long Non-Coding RNA GOMAFU in Schizophrenia: Function, Disease Risk, and Beyond

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Schizophrenia (SZ) is a complex neuropsychiatric disorder with poorly understood origins.
• Both genetic and environmental factors contribute to SZ, involving numerous genes and pathways.
• Non-coding RNAs, particularly long non-coding RNAs (lncRNAs), are increasingly recognized for their role in SZ pathogenesis.

Purpose of the Study:

• To review the role of the lncRNA GOMAFU (also known as MIAT and RNCR2) in neuronal development.
• To explore GOMAFU's potential as a risk factor and biomarker for schizophrenia.
• To discuss the molecular mechanisms underlying GOMAFU's function and its dysregulation in SZ.

Main Methods:

• Literature review focusing on GOMAFU's function in neuronal development.
• Analysis of genetic alterations and dysregulation of lncRNA genes in SZ.
• Examination of GOMAFU's molecular interactions and subcellular localization.

Main Results:

• GOMAFU plays a role in governing neuronal development.
• Alterations in GOMAFU are associated with schizophrenia.
• GOMAFU interacts with RNA-binding proteins and has specific subcellular localization.

Conclusions:

• GOMAFU is a significant lncRNA implicated in the pathogenesis of schizophrenia.
• GOMAFU's function in neuronal development and its dysregulation offer potential therapeutic targets.
• Further research into GOMAFU pathways is crucial for understanding and treating SZ.